{"nct_id":"NCT00538434","title":"Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years","status":"COMPLETED","status_verified_date":"2016-07","start_date":"2008-03","start_date_type":null,"primary_completion_date":"2009-10","primary_completion_date_type":"ACTUAL","completion_date":"2009-10","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["TEVA"]}